申请人:Boehringer Ingelheim GmbH
公开号:US04038279A1
公开(公告)日:1977-07-26
Compounds of the formula ##STR1## wherein R is phenyl; phenyl having one or two substituents attached thereto, said substituents being selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylthio of 1 to 4 carbon atoms, chlorine and trifluoromethyl; naphthyl; tetrahydronaphthyl; indanyl; pyridyl; isoquinolyl; or thiazolyl; R.sub.1 is ##STR2## where B is ##STR3## or ##STR4## R.sub.3 is hydrogen, alkyl of 1 to 4 carbon atoms, R.sub.4 and R.sub.5 are each hydrogen or alkyl of 1 to 4 carbon atoms, and Q is oxygen or two hydrogens, R.sub.2 is hydrogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen, A is a single carbon-to-carbon bond or --OCH.sub.2 --, R.sub.6 is hydrogen, hydroxyl, alkoxy of 1 to 4 carbon atoms or alkanoyloxy of 1 to 4 carbon atoms, and m is 0, 1, 2, 3, 4 or 5, but other than 0 when R.sub.6 is hydroxyl, And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as CNS-depressants, adrenolytics, antiphologistics, analgesics, antihistaminic and anticholesteremics.
化合物的公式为##STR1##其中R为苯基;苯基有一个或两个取代基,所述取代基选自由1至4个碳原子的烷基,1至4个碳原子的烷氧基,1至4个碳原子的烷
硫基,
氯和三
氟甲基的群;
萘基;四氢
萘基;
吲哚基;
吡啶基;
异喹啉基;或
噻唑基;R.sub.1为##STR2##其中B为##STR3##或##STR4##R.sub.3为氢,1至4个碳原子的烷基,R.sub.4和R.sub.5分别为氢或1至4个碳原子的烷基,Q为氧或两个氢,R.sub.2为氢,1至4个碳原子的烷基,1至4个碳原子的烷氧基或卤素,A为单个碳-碳键或--OCH.sub.2 --,R.sub.6为氢,羟基,1至4个碳原子的烷氧基或1至4个碳原子的烷酰氧基,m为0、1、2、3、4或5,但当R.sub.6为羟基时,m不为0;以及其非毒性、药理学上可接受的酸盐;这些化合物及其盐可用作中枢神经系统
抑制剂、
肾上腺素受体阻滞剂、抗炎剂、镇痛剂、抗
组胺剂和降
胆固醇剂。